Tag: life sciences
-
Univ. Spin-Off Creating Baby Brain Development Food
A start-up enterprise spun-off from the Duke-NUS medical school in Singapore is licensing research for a new food product for mothers to help a baby’s cognitive development.
-
Trial to Examine Immune System Workings
Unlike conventional clinical studies testing a particular treatment, this trial aims to explore in more detail the body’s interactions with a class of drugs, in this case vaccines.
-
$2 Billion Biotech Licensing Deal Cancelled
A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday.
-
Growing Engineered Algae Outdoors Shown Feasible, Safe
A test of cultivating genetically engineered algae in outdoor tanks shows the production technique is feasible and does not pose risks to native algae populations.
-
Synthetic Retina Developed with Natural Materials
A chemistry lab in the U.K. developed a synthetic retina made of natural materials resembling human tissue that in lab tests detects static, moving, and grey-scale images.
-
Gene Therapy Start-Up Raises $41M in Early Funds
A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round.
-
23andMe, Grünenthal Partner on Pain Genetics
A personal genetics company in Silicon Valley is collaborating with a German pharmaceutical company to better understand the relationship between genetics and pain.
-
Stem Cell Parkinson’s Model Devised for Drug Screening
A team from University at Buffalo created brain cells from adult stem cells that in lab tests display the same nerve misfirings seen in people with Parkinson’s disease.
-
Paper-Metal Antimicrobial Layers Designed
A lab at Rutgers University devised a method for sending an electric current through inexpensive paper and metal layered surfaces, which in lab tests kills harmful microbes.
-
Shire Licensing Dry Eye Disease Treatment in $535M Deal
An experimental drug for treating dry eye disease, a common disorder affecting older individuals, is being licensed by international pharmaceutical company Shire plc.